quadazocine has been researched along with 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide in 1 studies
Studies (quadazocine) | Trials (quadazocine) | Recent Studies (post-2010) (quadazocine) | Studies (4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide) | Trials (4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide) | Recent Studies (post-2010) (4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide) |
---|---|---|---|---|---|
81 | 0 | 0 | 279 | 0 | 85 |
Protein | Taxonomy | quadazocine (IC50) | 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide (IC50) |
---|---|---|---|
Delta-type opioid receptor | Mus musculus (house mouse) | 0.0842 | |
Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0879 | |
Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 4.7722 | |
Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 3.601 | |
Mu-type opioid receptor | Homo sapiens (human) | 1.8083 | |
Delta-type opioid receptor | Homo sapiens (human) | 0.0086 | |
Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 3.85 | |
Kappa-type opioid receptor | Homo sapiens (human) | 2.48 | |
Mu-type opioid receptor | Mus musculus (house mouse) | 6.066 | |
Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 10 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brandt, MR; Furness, MS; Mello, NK; Negus, SS; Rice, KC; Zhang, X | 1 |
1 other study(ies) available for quadazocine and 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide
Article | Year |
---|---|
Discriminative stimulus effects of the nonpeptidic delta-opioid agonist SNC80 in rhesus monkeys.
Topics: Analgesics, Opioid; Animals; Azocines; Benzamides; Discrimination Learning; Dose-Response Relationship, Drug; Female; Macaca mulatta; Male; Naltrexone; Narcotic Antagonists; Piperazines; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Stereoisomerism | 1999 |